StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a report released on Sunday morning. The firm issued a hold rating on the stock.
Milestone Scientific Stock Up 4.2 %
Shares of NYSE:MLSS opened at $1.01 on Friday. The stock has a market cap of $78.67 million, a price-to-earnings ratio of -14.43 and a beta of 1.41. Milestone Scientific has a 52-week low of $0.54 and a 52-week high of $1.39. The business has a 50-day moving average price of $1.11 and a 200-day moving average price of $0.96.
Institutional Trading of Milestone Scientific
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the period. Carnegie Investment Counsel grew its holdings in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after acquiring an additional 27,412 shares during the period. Renaissance Technologies LLC grew its holdings in Milestone Scientific by 72.8% during the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after acquiring an additional 53,198 shares during the period. World Investment Advisors LLC acquired a new stake in Milestone Scientific during the third quarter worth about $91,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific during the third quarter worth about $48,000. 5.79% of the stock is owned by institutional investors and hedge funds.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- How to Find Undervalued Stocks
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Stock Splits, Do They Really Impact Investors?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.